P

Inventor

VREES TAMMY

CA22 patents
⚠️ This page may combine multiple inventors who share the name “VREES TAMMY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SYN X PHARMA INC

14 patents
US6890763B2May 10, 2005

Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons

SYN X PHARMA INC79 citations98
US6627606B2Sep 30, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons

SYN X PHARMA INC18 citations92
US6620786B2Sep 16, 2003

Biopolymer marker indicative of disease state having molecular weight of 2937 daltons

SYN X PHARMA INC19 citations92
US6617308B2Sep 9, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons

SYN X PHARMA INC18 citations92
US6602855B2Aug 5, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons

SYN X PHARMA INC26 citations92
US6756476B2Jun 29, 2004

Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons

SYN X PHARMA INC14 citations84
US6627608B2Sep 30, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons

SYN X PHARMA INC15 citations84
US6620787B2Sep 16, 2003

Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons

SYN X PHARMA INC16 citations84
US6599877B2Jul 29, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons

SYN X PHARMA INC13 citations84
US6593298B2Jul 15, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons

SYN X PHARMA INC16 citations84
US6627607B2Sep 30, 2003

Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons

SYN X PHARMA INC12 citations74
US7049397B2May 23, 2006

Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons

SYN X PHARMA INC4 citations63
US7087435B2Aug 8, 2006

Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons

SYN X PHARMA INC0 citations52
US6998243B2Feb 14, 2006

Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons

SYN X PHARMA INC1 citations52

ARTEMIS PROTEOMICS LTD

3 patents
US7229638B2Jun 12, 2007

Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons

ARTEMIS PROTEOMICS LTD0 citations49
US7125726B2Oct 24, 2006

Method and kit for diagnosing myocardial infarction

ARTEMIS PROTEOMICS LTD1 citations49
US7008800B2Mar 7, 2006

Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons

ARTEMIS PROTEOMICS LTD0 citations49

NANOGEN INC

2 patents
US7314717B2Jan 1, 2008

Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons

NANOGEN INC10 citations84
US7294688B2Nov 13, 2007

Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons

NANOGEN INC5 citations63

SYN X PHARMA

2 patents
US6677303B2Jan 13, 2004

Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons

SYN X PHARMA16 citations83
US6693080B2Feb 17, 2004

Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons

SYN X PHARMA0 citations51

(unassigned)

1 patent
US6703366B2Mar 9, 2004

Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons

15 citations84